A population pharmacokinetic/pharmacodynamic model for the mobilization of progenitor cells by AMD3100.

被引：0
|
作者：
Green, B [1 ]
Lee, H [1 ]
Lack, N [1 ]
Dale, D [1 ]
Calandra, G [1 ]
MacFarland, R [1 ]
Badel, K [1 ]
Liles, W [1 ]
Bridger, G [1 ]
Peck, C [1 ]
机构：
[1] Univ Washington, Ctr Drug Dev Sci, AnorMED Inc, Washington, DC USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 77卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2004.12.245
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P92 / P92
页数：1
相关论文
共 50 条
  • [1] A pharmacokinetic-pharmacodynamic model for the mobilization of CD34+ hematopoietic progenitor cells by AMD3100
    Lack, NA
    Green, B
    Dale, DC
    Calandra, GB
    Lee, H
    MacFarland, RT
    Badel, K
    Liles, WC
    Bridger, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (05) : 427 - 436
  • [2] A pharmacokinetic/pharmacodynamic profile of the CXCR4 antagonist AMD3100 for the mobilization of hematopoietic progenitor cells.
    Lack, NA
    Dale, DC
    Calandra, G
    MacFarland, RT
    Badel, K
    Liles, WC
    BLOOD, 2003, 102 (11) : 115A - 115A
  • [3] Kinetics of human and marine mobilization of acute myeloid leukemia in response to AMD3100.
    Uy, Geoffrey L.
    Rettig, Michael P.
    Ramirez, Pablo
    Nervi, Bruno
    Abboud, Camille N.
    DiPersio, John F.
    BLOOD, 2007, 110 (11) : 265A - 266A
  • [4] Maximizing mobilization of hematopoietic stem and progenitor cells (HSPC) by AMD3100 and characterization of phenotype, function and cell cycling of AMD3100 mobilized HSPC
    Bonig, H.
    Papayannopoulou, T.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 49 - 49
  • [5] Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
    Liles, WC
    Broxmeyer, HE
    Rodger, E
    Wood, B
    Hübel, K
    Cooper, S
    Hangoc, G
    Bridger, GJ
    Henson, GW
    Calandra, G
    Dale, DC
    BLOOD, 2003, 102 (08) : 2728 - 2730
  • [6] Enhancement of G-CSF mobilization of human BM CD34+ cells with AMD3100: Substantial increase in the frequency of repopulating cells through tandem administration of G-CSF and AMD3100.
    Srour, EF
    Plett, AP
    Dale, DC
    Liles, C
    Calandra, GB
    Orschell, CM
    BLOOD, 2003, 102 (11) : 455A - 455A
  • [7] RESCUE MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS WITH AMD3100+G-CSF IS SUCCESSFUL IN PATIENTS WHO PREVIOUSLY FAILED MOBILIZATION
    Micallef, I. N. M.
    Ansell, S. M.
    Buadi, F.
    Dispenzieri, A.
    Elliott, M. A.
    Gertz, M. A.
    Hayman, S. R.
    Hogan, W. J.
    Inwards, D. J.
    Gastineau, D. A.
    Johnston, P. B.
    Kumar, S.
    Lacy, M. Q.
    Porrata, L. F.
    Marzolf, M.
    Shaw, T.
    Winters, J. L.
    Calandra, G.
    Litzow, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 94 - 94
  • [8] Mobilization of bone marrow stem/progenitor cells by AMD3100 or G-CSF is impaired in diabetes
    Vasam, Goutham
    Bartelmez, Stephen
    Jarajapu, Yagna
    FASEB JOURNAL, 2014, 28 (01):
  • [9] Kinetics of hematopoietic progenitor cell mobilization with cyclophosphamide or cyclophosphamide plus AMD3100 using a mouse model
    Gai, BQ
    Holt, MS
    Nervi, B
    Rettig, MP
    Ritchey, JK
    Bridger, G
    DiPersio, JF
    BLOOD, 2005, 106 (11) : 388B - 388B
  • [10] Potent stem cell mobilization by AMD3100 infusion, and functional analysis of AMD3100 mobilized cells
    Bonig, H.
    Papayannopoulou, T.
    VOX SANGUINIS, 2008, 95 : 27 - 27
12345